comprimé gastro-résistant clinical trials
6 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
Evaluation of a modified Anti-Platelet Therapy associated with low-dose rapamycin DES Firehawk in Acute Myocardial Infarction Patients treated with complete revascularization strategy (TARGET-FIRST)
This study looks at different blood-thinning medicines given after a heart attack to see which combinations best prevent serious problems like another heart attack, stroke, or severe bleeding. It's for adults of all ages, men and women, who have recently had a heart attack.
For: Acute Myocardial InfarctionSpain · Netherlands · Italy - AuthorisedPhase II and Phase III (Integrated)
Apixaban/rivaroxaban Versus Aspirin for primary prevention of thrombo-embolic complications in JAK2V617F-positive myeloproliferative neoplasms
This study compares new blood thinners (apixaban/Eliquis, rivaroxaban/Xarelto) with aspirin to see which best prevents blood clots in people with certain bone marrow conditions (myeloproliferative neoplasms) like Polycythemia Vera. It also looks at side effects, like bleeding.
For: Philadelphia-negative myeloproliferative neoplasms are frequent and chronic myeloid malignancies including Polycythemia Vera (PV) · essential thrombocythemia (ET) · Primary Myelofibrosis (PMF) and Prefibrotic myelofibrosis (PreMF).France - AuthorisedTherapeutic confirmatory (Phase III)
SERORL Effect of aspirin and folic acid for sudden sensorineural hearing loss
This study looks at how aspirin and folic acid might help people with sudden hearing loss in one ear. Doctors want to see if these treatments can improve hearing compared to not taking them. It's a key step to find better ways to help people regain their hearing.
For: occurs within a 72 hour window · no other types of hearing loss as conductive forms of hearing impairment. 4. No history of fluctuating sensorineural hearing loss or otologic disease.France - AuthorisedTherapeutic use (Phase IV)
PTX3 genetically stratified randomized double-blinded allocation event-driven clinical trial for antifungal prophylaxis in patients with acute myeloid leukemia
This study looks at different medicines to prevent fungal infections in people with a type of blood cancer called acute myeloid leukaemia. It compares how well these medicines work over 6 months to keep people healthy.
For: Antifungal prophylaxis in patients with acute myeloid leukemiaBelgium · France - AuthorisedTherapeutic confirmatory (Phase III)
ASPAPY - Aspirin in acute pneumonia in the elderly: a multicenter, double-blind, randomized, placebo-controlled trial
This study is looking at whether aspirin can help older people with severe pneumonia. Researchers want to see if taking aspirin changes how many people die within 90 days after getting pneumonia, compared to a dummy drug.
For: acute pneumoniaFrance - AuthorisedTherapeutic use (Phase IV)
Short-Term Anticoagulation versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure. The ANDES study.
This study, called ANDES, looks at different blood-thinning medicines given for a short time after a procedure called Left Atrial Appendage Closure (LAAC). It aims to find the best way to prevent blood clots forming on the device used in the heart, especially for people with an irregular heartbeat.
For: Atrial Fibrillation Device thrombosis post-Left Atrial Appendage ClosureSpain